Annual report pursuant to Section 13 and 15(d)

Nature of Operations and Basis of Presentation (Details Narrative)

v3.5.0.2
Nature of Operations and Basis of Presentation (Details Narrative)
May 18, 2015
shares
Jun. 03, 2011
USD ($)
Jul. 31, 2016
Subsidiary
Number of subsidiaries | Subsidiary     0
Number of fractional shares issued related to reverse stock split | shares 20    
Onco Sec Medical Therapeutics Incorporated [Member]      
Total purchase price | $   $ 1,000